Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04487301 · ClinicalTrials.gov registry record
A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
A clinical trial of Peripheral Artery Disease and End Stage Renal Disease on Dialysis, sponsored by Sanifit Therapeutics S. A..
- Completed
- Registry status
- 36
- Enrollment target
- 7
- Study locations
NCT04487301: Completed study of Peripheral Artery Disease and End Stage Renal Disease on Dialysis, sponsored by Sanifit Therapeutics S. A..
NCT04487301 is a study of Peripheral Artery Disease and End Stage Renal Disease on Dialysis that has completed, run by Sanifit Therapeutics S. A.. The registered enrollment target is 36 participants, below the 126-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (71% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04487301, a study of Peripheral Artery Disease and End Stage Renal Disease on Dialysis, has completed, sponsored by Sanifit Therapeutics S. A..
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
- 7
- Study locations
Study Summary
A cross-sectional, non-interventional study to assess walking performance, vascular function, and lower limb calcification in subjects with peripheral artery disease and end-stage kidney disease (PAD-ESKD) receiving hemodialysis.
Primary Outcome
Walking distance in meters completed over a duration of 6 minutes
Conditions Studied
Study Locations (7)
Massachusetts
- Brigham and Women's Hospital - Boston
- Boston Medical Center - Boston
California
- Valley Renal Medical Group - Northridge
Florida
- Horizon Medical Research - Coral Gables
Missouri
- St Louis Kidney Care - St Louis
North Carolina
- Mountain Kidney & Hypertension Associates - Asheville
Texas
- Houston Medical Research - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2021-06-12 |
What the finished NCT04487301 record still lists
NCT04487301 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 126-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (71% lower).
The record links to 2 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04487301 lists 7 locations in 6 states (Massachusetts, California, Florida).
Frequently Asked Questions
What is clinical trial NCT04487301 about?
NCT04487301 is a clinical study titled "A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease". A cross-sectional, non-interventional study to assess walking performance, vascular function, and lower limb calcification in subjects with peripheral artery disease and end-stage kidney disease (PAD-ESKD) receiving hemodialysis.
What is the current status of trial NCT04487301?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2020-11-16. Estimated completion is 2021-06-12.
What conditions does trial NCT04487301 study?
This clinical trial studies the following conditions: Peripheral Artery Disease, End Stage Renal Disease on Dialysis.
Who is sponsoring clinical trial NCT04487301?
This trial is sponsored by Sanifit Therapeutics S. A., which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04487301 being conducted?
This trial has 7 study locations across California, Florida, Massachusetts, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04487301's enrollment target sits among peer trials
36 32nd of 50 higher than 19 of 50 other Peripheral Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Response to Exercise and Nitric Oxide in PAD
RECRUITING · Phase 2
-
The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
RECRUITING · Phase 1
-
Improving Mobility After Revascularization in Peripheral Artery Disease
RECRUITING · Phase 3
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI